Gordon Carl L's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Jul 17, 2024
- Accession no.
- 0000947871-24-000628
- Filed
- Jul 17, 2024
- Trade date
- Jul 15-16, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 6 non-derivative transactions and 0 derivative transactions. Open-market sales total $561.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon Carl LCIK 0001282930 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2024 | Common Stock | SSaleDisposed | −39,433 | $10.00 | −$394,330 | 4,843,421 | Indirect | |
| Jul 15, 2024 | Common Stock | SSaleDisposed | −5,401 | $10.00 | −$54,010 | 1,968,480 | Indirect | |
| Jul 15, 2024 | Common Stock | SSaleDisposed | −6,142 | $10.00 | −$61,420 | 756,258 | Indirect | |
| Jul 16, 2024 | Common Stock | SSaleDisposed | −4,009 | $10.00 | −$40,090 | 4,839,412 | Indirect | |
| Jul 16, 2024 | Common Stock | SSaleDisposed | −556 | $10.00 | −$5,560 | 1,967,924 | Indirect | |
| Jul 16, 2024 | Common Stock | SSaleDisposed | −623 | $10.00 | −$6,230 | 755,635 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.